Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.22M |
| 2 |
Meta Platforms (Facebook)
META
|
+$6.1M |
| 3 |
Boston Scientific
BSX
|
+$5.72M |
| 4 |
Accenture
ACN
|
+$5.66M |
| 5 |
Expedia Group
EXPE
|
+$4.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$14.8M |
| 2 |
Oracle
ORCL
|
+$10.3M |
| 3 |
Walt Disney
DIS
|
+$9.89M |
| 4 |
Apple
AAPL
|
+$9.74M |
| 5 |
Wells Fargo
WFC
|
+$8.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.64% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 15.86% |
| 4 | Industrials | 12.65% |
| 5 | Financials | 6.86% |
Similar funds
Bayesian Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Bayesian Capital Management held 855 positions worth $490M, down 23% from $633M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Bayesian Capital Management withdrew a net $164M in Q3 2025, closing 352 positions and reducing 95 holdings. Its most notable exit was Nike, an estimated $14.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Microsoft worth $6.32M.
- Bayesian Capital Management's largest Q3 2025 buy was Microsoft: 12,200 shares worth $6.32M.
- Bayesian Capital Management added most to Idexx Laboratories in Q3 2025, an estimated $3.81M increase.
- Bayesian Capital Management's biggest Q3 2025 reduction was Walt Disney, cutting an estimated $9.89M.
- Bayesian Capital Management fully exited Nike in Q3 2025, selling an estimated $14.8M.
- Bayesian Capital Management's ten largest holdings make up 10% of its $490M portfolio in Q3 2025.
- Bayesian Capital Management opened 346 new positions and closed 352 in Q3 2025.
- Bayesian Capital Management's portfolio value fell 23% quarter-over-quarter to $490M.
Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.